|
TTC13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.821000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.693610E-01 |
| Normal-vs-Stage2 |
1.132380E-01 |
| Normal-vs-Stage3 |
9.967600E-01 |
| Normal-vs-Stage4 |
8.384000E-01 |
| Stage1-vs-Stage2 |
2.745900E-02 |
| Stage1-vs-Stage3 |
1.639020E-01 |
| Stage1-vs-Stage4 |
2.378600E-01 |
| Stage2-vs-Stage3 |
1.084970E-01 |
| Stage2-vs-Stage4 |
1.267200E-01 |
| Stage3-vs-Stage4 |
8.299400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.621800E-01 |
| Normal-vs-AfricanAmerican |
1.939620E-01 |
| Normal-vs-Asian |
1.593850E-01 |
| Caucasian-vs-AfricanAmerican |
8.648000E-01 |
| Caucasian-vs-Asian |
8.956400E-01 |
| AfricanAmerican-vs-Asian |
9.629800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.093200E-01 |
| Normal-vs-Female |
9.266600E-01 |
| Male-vs-Female |
2.108200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.583610E-01 |
| Normal-vs-Age(41-60Yrs) |
5.529600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.391200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.796400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.059190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.657190E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.281200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.399400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.184400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.627400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.687720E-02 |
| Classical-VS-Follicular |
1.801840E-03 |
| Classical-VS-Other |
9.664600E-01 |
| Classical-VS-Normal |
7.847600E-02 |
| Tall-VS-Follicular |
4.823800E-01 |
| Tall-VS-Other |
9.066000E-02 |
| Tall-VS-Normal |
2.832800E-01 |
| Follicular-VS-Other |
4.064500E-02 |
| Follicular-VS-Normal |
3.814500E-02 |
| Other-VS-Normal |
2.099600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.031800E-01 |
| Normal-vs-N1 |
5.529000E-01 |
| N0-vs-N1 |
2.308000E-01 |
|
|
